Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration.

Swan D, Long J, Carr O, Flanagan J, Irish H, Keating S, Keaveney M, Lambert J, McCormick PA, McKiernan S, Moloney J, Perry N, Cullen W.

AIDS Patient Care STDS. 2010 Dec;24(12):753-62. doi: 10.1089/apc.2010.0142.

PMID:
21138381
2.

Factors that influence an HIV coinfected patient's decision to start hepatitis C treatment.

Osilla KC, Ryan G, Bhatti L, Goetz M, Witt M, Wagner G.

AIDS Patient Care STDS. 2009 Dec;23(12):993-9. doi: 10.1089/apc.2009.0153.

3.

Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population.

Scott JD, Wald A, Kitahata M, Krantz E, Drolette L, Corey L, Wang CC.

AIDS Patient Care STDS. 2009 Nov;23(11):925-9. doi: 10.1089/apc.2009.0099.

4.

Treat early or wait and monitor? A qualitative analysis of provider hepatitis C virus treatment decision-making in the context of HIV coinfection.

Wagner G, Ryan G, Osilla KC, Bhatti L, Goetz M, Witt M.

AIDS Patient Care STDS. 2009 Sep;23(9):715-25. doi: 10.1089/apc.2009.0049.

5.

HCV treatment decision-making substance use experiences and hepatitis C treatment decision-making among HIV/HCV Coinfected Adults.

Ogawa LM, Bova C.

Subst Use Misuse. 2009;44(7):915-33. doi: 10.1080/10826080802486897.

PMID:
19440928
6.

Hepatitis C protease and polymerase inhibitors in development.

Liu-Young G, Kozal MJ.

AIDS Patient Care STDS. 2008 Jun;22(6):449-57. doi: 10.1089/apc.2007.0199. Review.

7.

Changing trends in hepatitis C-related mortality in the United States, 1995-2004.

Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F.

Hepatology. 2008 Apr;47(4):1128-35. doi: 10.1002/hep.22165.

PMID:
18318441
8.

Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.

Munoz-Plaza CE, Strauss S, Astone-Twerell J, Jarlais DD, Gwadz M, Hagan H, Osborne A, Rosenblum A.

Int J Drug Policy. 2008 Feb;19(1):71-8. doi: 10.1016/j.drugpo.2007.02.003. Epub 2007 Aug 6.

9.

Limited uptake of hepatitis C treatment among injection drug users.

Mehta SH, Genberg BL, Astemborski J, Kavasery R, Kirk GD, Vlahov D, Strathdee SA, Thomas DL.

J Community Health. 2008 Jun;33(3):126-33. doi: 10.1007/s10900-007-9083-3.

10.

Barriers associated with the treatment of hepatitis C virus infection among illicit drug users.

Grebely J, Genoway KA, Raffa JD, Dhadwal G, Rajan T, Showler G, Kalousek K, Duncan F, Tyndall MW, Fraser C, Conway B, Fischer B.

Drug Alcohol Depend. 2008 Jan 11;93(1-2):141-7. Epub 2007 Nov 9.

PMID:
17997050
11.

Factors that help injecting drug users to access and benefit from services: A qualitative study.

Neale J, Sheard L, Tompkins CN.

Subst Abuse Treat Prev Policy. 2007 Oct 30;2:31.

12.
13.

Relaxing the rule of ten events per variable in logistic and Cox regression.

Vittinghoff E, McCulloch CE.

Am J Epidemiol. 2007 Mar 15;165(6):710-8. Epub 2006 Dec 20.

PMID:
17182981
14.

Rate and predictors of treatment prescription for hepatitis C.

Butt AA, Justice AC, Skanderson M, Rigsby MO, Good CB, Kwoh CK.

Gut. 2007 Mar;56(3):385-9. Epub 2006 Sep 27.

15.

What do patients consider when making decisions about treatment for hepatitis C?

Fraenkel L, McGraw S, Wongcharatrawee S, Garcia-Tsao G.

Am J Med. 2005 Dec;118(12):1387-91.

PMID:
16378783
16.

Primary care provider attitudes are associated with smoking cessation counseling and referral.

Meredith LS, Yano EM, Hickey SC, Sherman SE.

Med Care. 2005 Sep;43(9):929-34.

PMID:
16116358
17.

Starting or changing therapy - a prospective study exploring antiretroviral decision-making.

Fehr JS, Nicca D, Sendi P, Wolf E, Wagels T, Kiss A, Bregenzer T, Vernazza P, Jäger H, Spirig R, Battegay M; Swiss HIV Cohort Study.

Infection. 2005 Aug;33(4):249-56.

PMID:
16091895
18.

Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.

Bini EJ, Bräu N, Currie S, Shen H, Anand BS, Hu KQ, Jeffers L, Ho SB, Johnson D, Schmidt WN, King P, Cheung R, Morgan TR, Awad J, Pedrosa M, Chang KM, Aytaman A, Simon F, Hagedorn C, Moseley R, Ahmad J, Mendenhall C, Waters B, Strader D, Sasaki AW, Rossi S, Wright TL.

Am J Gastroenterol. 2005 Aug;100(8):1772-9.

PMID:
16086714
19.
20.

Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin.

Rauch A, Egger M, Reichen J, Furrer H; Swiss HIV Cohort Study.

J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):238-40. No abstract available.

PMID:
15671812

Supplemental Content

Support Center